Trazodone and Muscle Relaxant Co-administration Safety

Mechanism of Concern

• Muscle relaxants act on the central nervous system or directly on skeletal muscles to reduce muscle tone and spasticity 1, 2
• The combination of trazodone and muscle relaxants may lead to enhanced CNS depression, potentially affecting respiratory function and level of consciousness 1

Risk Assessment

Potential Adverse Effects

• Risk of respiratory depression in vulnerable populations 1, 3

High-Risk Populations

• Patients with neuromuscular diseases are at higher risk 4
• Patients with respiratory compromise are at higher risk 3
• Patients with hepatic or renal impairment are at higher risk 4

Clinical Recommendations

Monitoring Requirements

• Monitor for excessive sedation and respiratory depression when using muscle relaxants with trazodone 1
• Quantitative monitoring is essential when using muscle relaxants, especially when combined with other CNS depressants 5

Dosing Considerations

• Consider using benzylisoquinoline muscle relaxants (atracurium/cisatracurium) in patients with renal/hepatic failure 4
• Adjust dosing based on monitoring of neuromuscular function 5

Special Populations

• In patients with neuromuscular disease, monitoring of neuromuscular blockade is recommended following muscle relaxant use 6
• Consider using sugammadex for reversal of steroidal muscle relaxants in patients with neuromuscular disease 4

Alternative Approaches

• Consider non-pharmacological approaches for muscle relaxation when possible 2

Common Pitfalls to Avoid

• Do not overlook monitoring requirements, especially in outpatient settings 5